Improving smoking cessation through telehealth in primary care
Hybrid Type 1 Effectiveness-Implementation Trial of a Proactive Smoking Cessation Electronic Visit for Scalable Delivery Via Primary Care
This study is testing if an online visit can help people quit smoking better than regular care by offering support and possibly medication.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 672 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Medical University of South Carolina Academic / other |
| Locations | 1 site (Charleston, South Carolina) |
| Trial ID | NCT05493254 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of an electronic visit (e-visit) designed to assist individuals in quitting smoking. Participants will be randomly assigned to either receive the e-visit, which includes a questionnaire about their smoking habits and preferences for cessation medications, or to a control group receiving standard care. The study will track participants over 24 weeks, collecting data through questionnaires and breath samples at four different time points. The e-visit may lead to a prescription for smoking cessation medication, although taking medication is not mandatory.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who smoke at least one cigarette per day and have been smoking for the past six months.
Not a fit: Patients who have used FDA-approved cessation medications in the last week will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance smoking cessation rates among participants.
How similar studies have performed: Other studies have shown promising results using telehealth interventions for smoking cessation, indicating that this approach is supported by prior research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. current smoking, defined as 1+ cigarettes/day, for 20+ days out of the last 30 for the last 6+ months 2. age 18+ 3. enrolled in MyChart or willing to enroll 4. possess a valid e-mail address that is checked daily 5. owner of an iOS or Android smartphone to provide remote CO 6. have a valid mailing address 7. English fluency Exclusion Criteria: 1\) Use of an FDA-approved cessation medication in the last 7 days
Where this trial is running
Charleston, South Carolina
- Medical University of South Carolina — Charleston, South Carolina, United States (Recruiting)
Study contacts
- Study coordinator: Noelle E Natale
- Email: natalen@musc.edu
- Phone: 843-876-2426
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.